Condition: Breast Cancer · Sponsor: ETOP IBCSG Partners Foundation
RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormone therapy using triptorelin, exemestane, and tamoxifen may fight breast cancer by blocking the use of estrogen. It is not yet known whether giving triptorelin together with exemestane is more effective than triptorelin and tamoxifen in treating hormone-responsive breast cancer. PURPOSE: This randomized phase III trial is studying triptorelin and exemestane to see how well they work compared to triptorelin and tamoxifen in treating premenopausal women with hormone-responsive breast cancer.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center | Burbank, California, United States | — |
| Rebecca and John Moores UCSD Cancer Center | La Jolla, California, United States | — |
| Providence Holy Cross Cancer Center | Mission Hills, California, United States | — |
| Desert Regional Medical Center Comprehensive Cancer Center | Palm Springs, California, United States | — |
| Sutter Cancer Center at Roseville Medical Center | Roseville, California, United States | — |
| Sutter Cancer Center | Sacramento, California, United States | — |
| Mercy General Hospital | Sacramento, California, United States | — |
| UCSF Helen Diller Family Comprehensive Cancer Center | San Francisco, California, United States | — |
| Ruby L. Golleher Cancer Program at Presbyterian Intercommunity Hospital | Whittier, California, United States | — |
| University of Colorado Cancer Center at UC Health Sciences Center | Aurora, Colorado, United States | — |
| Shaw Regional Cancer Center | Edwards, Colorado, United States | — |
| Poudre Valley Hospital | Fort Collins, Colorado, United States | — |
+ 216 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.